Literature DB >> 20567233

Functional osteoclast attachment requires inositol-1,4,5-trisphosphate receptor-associated cGMP-dependent kinase substrate.

Beatrice B Yaroslavskiy1, Irina Turkova, Yujuan Wang, Lisa J Robinson, Harry C Blair.   

Abstract

Osteoclast activity is central to balanced bone turnover to maintain normal bone mass. A specialized osteoclast attachment to bone localizes acid secretion to remove bone mineral; in some cases, attachment is functionally impaired despite normal attachment proteins. The inositol-1,4,5-trisphosphate receptor-1 (IP3R1) is an intracellular calcium channel required for regulation of reversible osteoclast attachment by nitric oxide (NO), an important regulator of both normal and pathological bone degradation. In studies using human osteoclasts produced in vitro, we found that IP3R1 binds an endosomal isoform of the IP3R-associated cGMP-dependent kinase substrate (IRAG). IRAG is a substrate of cGMP-dependent kinase-1 (PKG1) and binds the PKG1 isoform PKG1β, which was the predominant form of PKG1 in human osteoclasts. Western blots of IRAG were consistent with NO-dependent serine phosphorylation of IRAG. An additional effect of PKG1β activity in osteoclasts was disassociation of IP3R1-IRAG complexes, as shown by analysis of IP3R1 complexes and by localization of the proteins within cells. IP3R1-IRAG complexes were stabilized by PKG or Src antagonists, Src activity being a requirement for IP3R1 calcium release downstream of PKG. IP3R1-mediated calcium release regulates cellular detachment in part through the calcium-dependent proteinase μ-calpain. In osteoclasts with IRAG suppressed by siRNA, activity of μ-calpain was increased relative to cells with normal IRAG, and regulation of μ-calpain by NO was lost. Furthermore, cells deficient in IRAG detached easily from substrate and had smaller attached diameters and randomly distributed podosomes, although IRAG knockdown did not affect cell viability. Our results indicate that IRAG is required for PKG1β-regulated cyclic calcium release during motility, and that disruption of the IP3R1-IRAG calcium regulation system is a novel cause of dysfunctional osteoclasts unrelated to defects in attachment proteins or acid secretion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20567233      PMCID: PMC3114438          DOI: 10.1038/labinvest.2010.120

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  31 in total

1.  Regulation of the type 1 inositol 1,4,5-trisphosphate receptor by phosphorylation at tyrosine 353.

Authors:  Jie Cui; Scot J Matkovich; Nikhil deSouza; Suzhao Li; Nora Rosemblit; Andrew R Marks
Journal:  J Biol Chem       Date:  2004-02-03       Impact factor: 5.157

2.  Requirement of inositol 1,4,5-trisphosphate receptors for tumor-mediated lymphocyte apoptosis.

Authors:  Camia Steinmann; Megan L Landsverk; José M Barral; Darren Boehning
Journal:  J Biol Chem       Date:  2008-03-25       Impact factor: 5.157

3.  IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation.

Authors:  Melanie Antl; Marie-Luise von Brühl; Christina Eiglsperger; Matthias Werner; Ildiko Konrad; Thomas Kocher; Matthias Wilm; Franz Hofmann; Steffen Massberg; Jens Schlossmann
Journal:  Blood       Date:  2006-09-21       Impact factor: 22.113

4.  Phosphorylation of IP3R1 and the regulation of [Ca2+]i responses at fertilization: a role for the MAP kinase pathway.

Authors:  Bora Lee; Elke Vermassen; Sook-Young Yoon; Veerle Vanderheyden; Junya Ito; Dominique Alfandari; Humbert De Smedt; Jan B Parys; Rafael A Fissore
Journal:  Development       Date:  2006-11       Impact factor: 6.868

5.  Mrvi1, a common MRV integration site in BXH2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jaw1.

Authors:  J D Shaughnessy; D A Largaespada; E Tian; C F Fletcher; B C Cho; P Vyas; N A Jenkins; N G Copeland
Journal:  Oncogene       Date:  1999-03-25       Impact factor: 9.867

6.  Distribution of IRAG and cGKI-isoforms in murine tissues.

Authors:  A Geiselhöringer; M Gaisa; F Hofmann; J Schlossmann
Journal:  FEBS Lett       Date:  2004-09-24       Impact factor: 4.124

7.  Calcium-dependent and calcium-independent inhibition of contraction by cGMP/cGKI in intestinal smooth muscle.

Authors:  Eva Frei; Maria Huster; Petra Smital; Jens Schlossmann; Franz Hofmann; Jörg W Wegener
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-23       Impact factor: 4.052

8.  Selective phosphorylation of the IP3R-I in vivo by cGMP-dependent protein kinase in smooth muscle.

Authors:  Karnam S Murthy; Huiping Zhou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-02       Impact factor: 4.052

9.  Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-alpha with BCAR1 and Traf6.

Authors:  Lisa J Robinson; Beatrice B Yaroslavskiy; Reed D Griswold; Eva V Zadorozny; Lida Guo; Irina L Tourkova; Harry C Blair
Journal:  Exp Cell Res       Date:  2009-01-30       Impact factor: 3.905

10.  Osteopetrosis with micro-lacunar resorption because of defective integrin organization.

Authors:  Harry C Blair; Beatrice B Yaroslavskiy; Lisa J Robinson; Markus Y Mapara; Alessandra Pangrazio; Lida Guo; Ka Chen; Paolo Vezzoni; Jakub Tolar; Paul J Orchard
Journal:  Lab Invest       Date:  2009-06-22       Impact factor: 5.662

View more
  7 in total

1.  InsP3R-associated cGMP kinase substrate determines inositol 1,4,5-trisphosphate receptor susceptibility to phosphoregulation by cyclic nucleotide-dependent kinases.

Authors:  Wataru Masuda; Matthew J Betzenhauser; David I Yule
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

2.  A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.

Authors:  Hema Kalyanaraman; Ghania Ramdani; Jisha Joshua; Nadine Schall; Gerry R Boss; Esther Cory; Robert L Sah; Darren E Casteel; Renate B Pilz
Journal:  J Bone Miner Res       Date:  2016-09-07       Impact factor: 6.741

Review 3.  Calcium and bone disease.

Authors:  Harry C Blair; Lisa J Robinson; Christopher L-H Huang; Li Sun; Peter A Friedman; Paul H Schlesinger; Mone Zaidi
Journal:  Biofactors       Date:  2011-06-14       Impact factor: 6.113

Review 4.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

5.  Gene disruption of the calcium channel Orai1 results in inhibition of osteoclast and osteoblast differentiation and impairs skeletal development.

Authors:  Lisa J Robinson; Salvatore Mancarella; Duangrat Songsawad; Irina L Tourkova; John B Barnett; Donald L Gill; Jonathan Soboloff; Harry C Blair
Journal:  Lab Invest       Date:  2012-04-30       Impact factor: 5.662

Review 6.  Physical aspects of sensory transduction on seeing, hearing and smelling.

Authors:  Tohru Yoshioka; Manabu Sakakibara
Journal:  Biophysics (Nagoya-shi)       Date:  2013-12-26

Review 7.  Role of nitric oxide in orthodontic tooth movement (Review).

Authors:  Tong Yan; Yongjian Xie; Hongwen He; Wenguo Fan; Fang Huang
Journal:  Int J Mol Med       Date:  2021-07-19       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.